Secondly, GSDME has been shown to enhance the response to immunotherapy, as demonstrated by a pivotal study published in Nature in 2020, which revealed that GSDME-dependent cooperation between natural killer (NK) cells and CD8+ T cells significantly suppresses tumor progression in various models of melanoma and breast cancer (7). The gene discussed is GSDME; the disease is breast carcinoma.